Mettler-Toledo International (MTD) Competitors

$1,123.08 -196.21 (-14.87%)

Closing price 05/8/2026 03:59 PM Eastern

Extended Trading

$1,125.00 +1.92 (+0.17%)

As of 05/8/2026 07:59 PM Eastern

MTD vs. BRKR, RGEN, TECH, A, and BIO

Should you be buying Mettler-Toledo International stock or one of its competitors? The main competitors of Mettler-Toledo International include Bruker (BRKR), Repligen (RGEN), Bio-Techne (TECH), Agilent Technologies (A), and Bio-Rad Laboratories (BIO).

How does Mettler-Toledo International compare to Bruker?

Mettler-Toledo International (NYSE:MTD) and Bruker (NASDAQ:BRKR) are both life sciences tools & services companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 79.5% of Bruker shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 27.2% of Bruker shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Mettler-Toledo International has higher revenue and earnings than Bruker. Bruker is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03B	5.65	$869.19M	$42.12	26.66
Bruker	$3.44B	1.96	-$8.60M	-$0.24	N/A

In the previous week, Bruker had 2 more articles in the media than Mettler-Toledo International. MarketBeat recorded 20 mentions for Bruker and 18 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.79 beat Bruker's score of 0.59 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Bruker	6 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Bruker's net margin of -0.65%. Bruker's return on equity of 11.60% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-503.90%	25.19%
Bruker	-0.65%	11.60%	4.25%

Mettler-Toledo International currently has a consensus target price of $1,447.08, indicating a potential upside of 28.85%. Bruker has a consensus target price of $50.54, indicating a potential upside of 14.44%. Given Mettler-Toledo International's stronger consensus rating and higher possible upside, equities analysts clearly believe Mettler-Toledo International is more favorable than Bruker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Bruker	2 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.47

Mettler-Toledo International has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Bruker has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Bruker on 12 of the 16 factors compared between the two stocks.

How does Mettler-Toledo International compare to Repligen?

Mettler-Toledo International (NYSE:MTD) and Repligen (NASDAQ:RGEN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

95.1% of Mettler-Toledo International shares are owned by institutional investors. Comparatively, 97.6% of Repligen shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by company insiders. Comparatively, 0.6% of Repligen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Mettler-Toledo International has higher revenue and earnings than Repligen. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Repligen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mettler-Toledo International	$4.03B	5.65	$869.19M	$42.12	26.66
Repligen	$738.26M	9.43	$48.89M	$0.90	137.18

In the previous week, Repligen had 4 more articles in the media than Mettler-Toledo International. MarketBeat recorded 22 mentions for Repligen and 18 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.79 beat Repligen's score of 0.48 indicating that Mettler-Toledo International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Repligen	4 Very Positive mention(s)	1 Positive mention(s)	12 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Mettler-Toledo International has a net margin of 21.40% compared to Repligen's net margin of 6.73%. Repligen's return on equity of 4.88% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mettler-Toledo International	21.40%	-503.90%	25.19%
Repligen	6.73%	4.88%	3.48%

Mettler-Toledo International currently has a consensus target price of $1,447.08, indicating a potential upside of 28.85%. Repligen has a consensus target price of $169.62, indicating a potential upside of 37.38%. Given Repligen's stronger consensus rating and higher possible upside, analysts clearly believe Repligen is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mettler-Toledo International	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
Repligen	1 Sell rating(s)	2 Hold rating(s)	10 Buy rating(s)	2 Strong Buy rating(s)	2.87

Mettler-Toledo International has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Comparatively, Repligen has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Summary

Repligen beats Mettler-Toledo International on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Techne?

Bio-Techne (NASDAQ:TECH) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Bio-Techne currently has a consensus target price of $66.77, suggesting a potential upside of 38.07%. Mettler-Toledo International has a consensus target price of $1,447.08, suggesting a potential upside of 28.85%. Given Bio-Techne's stronger consensus rating and higher probable upside, research analysts clearly believe Bio-Techne is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Techne	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	2.79
Mettler-Toledo International	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54

Mettler-Toledo International has higher revenue and earnings than Bio-Techne. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Techne, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Techne	$1.22B	6.21	$73.40M	$0.69	70.09
Mettler-Toledo International	$4.03B	5.65	$869.19M	$42.12	26.66

In the previous week, Bio-Techne had 11 more articles in the media than Mettler-Toledo International. MarketBeat recorded 29 mentions for Bio-Techne and 18 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 0.79 beat Bio-Techne's score of -0.12 indicating that Mettler-Toledo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Techne	4 Very Positive mention(s)	6 Positive mention(s)	10 Neutral mention(s)	3 Negative mention(s)	2 Very Negative mention(s)	Neutral
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

99.0% of Bio-Techne shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Bio-Techne shares are owned by insiders. Comparatively, 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Techne's net margin of 9.05%. Bio-Techne's return on equity of 13.57% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Techne	9.05%	13.57%	10.66%
Mettler-Toledo International	21.40%	-503.90%	25.19%

Bio-Techne has a beta of 1.41, meaning that its stock price is 41% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.

Summary

Bio-Techne beats Mettler-Toledo International on 11 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Mettler-Toledo International (NYSE:MTD) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Agilent Technologies currently has a consensus target price of $163.71, suggesting a potential upside of 41.72%. Mettler-Toledo International has a consensus target price of $1,447.08, suggesting a potential upside of 28.85%. Given Agilent Technologies' stronger consensus rating and higher probable upside, research analysts clearly believe Agilent Technologies is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	3.00
Mettler-Toledo International	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54

Agilent Technologies has higher revenue and earnings than Mettler-Toledo International. Agilent Technologies is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$6.95B	4.70	$1.30B	$4.53	25.50
Mettler-Toledo International	$4.03B	5.65	$869.19M	$42.12	26.66

In the previous week, Mettler-Toledo International had 7 more articles in the media than Agilent Technologies. MarketBeat recorded 18 mentions for Mettler-Toledo International and 11 mentions for Agilent Technologies. Agilent Technologies' average media sentiment score of 1.02 beat Mettler-Toledo International's score of 0.79 indicating that Agilent Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

95.1% of Mettler-Toledo International shares are owned by institutional investors. 0.7% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Mettler-Toledo International has a net margin of 21.40% compared to Agilent Technologies' net margin of 18.26%. Agilent Technologies' return on equity of 24.49% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	18.26%	24.49%	12.83%
Mettler-Toledo International	21.40%	-503.90%	25.19%

Agilent Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.

Summary

Mettler-Toledo International beats Agilent Technologies on 9 of the 17 factors compared between the two stocks.

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Mettler-Toledo International is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bio-Rad Laboratories	$2.58B	2.66	$759.90M	$6.07	41.90
Mettler-Toledo International	$4.03B	5.65	$869.19M	$42.12	26.66

Bio-Rad Laboratories has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500.

65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 30.3% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 0.7% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Bio-Rad Laboratories presently has a consensus target price of $333.00, suggesting a potential upside of 30.92%. Mettler-Toledo International has a consensus target price of $1,447.08, suggesting a potential upside of 28.85%. Given Bio-Rad Laboratories' higher possible upside, equities analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bio-Rad Laboratories	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Mettler-Toledo International	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54

In the previous week, Mettler-Toledo International had 12 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 18 mentions for Mettler-Toledo International and 6 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 0.81 beat Mettler-Toledo International's score of 0.79 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bio-Rad Laboratories	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Mettler-Toledo International	9 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Mettler-Toledo International has a net margin of 21.40% compared to Bio-Rad Laboratories' net margin of 6.52%. Bio-Rad Laboratories' return on equity of 3.56% beat Mettler-Toledo International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bio-Rad Laboratories	6.52%	3.56%	2.49%
Mettler-Toledo International	21.40%	-503.90%	25.19%

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 11 of the 16 factors compared between the two stocks.

Get Mettler-Toledo International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MTD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MTD vs. The Competition

Export

Metric	Mettler-Toledo International	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$26.71B	$7.16B	$6.25B	$22.98B
Dividend Yield	N/A	1.71%	2.78%	4.01%
P/E Ratio	26.34	49.10	20.64	28.60
Price / Sales	5.65	56.50	534.02	110.85
Price / Cash	26.58	24.93	43.29	25.08
Price / Book	-968.17	5.81	9.98	4.62
Net Income	$869.19M	$158.34M	$3.54B	$1.07B
7 Day Performance	-11.58%	-0.39%	3.50%	0.46%
1 Month Performance	-15.56%	4.88%	4.17%	4.09%
1 Year Performance	3.99%	-0.25%	41.86%	28.48%

Mettler-Toledo International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MTD Mettler-Toledo International	3.9193 of 5 stars	$1,123.08 -14.9%	$1,447.08 +28.8%	N/A	$26.71B	$4.03B	26.34	18,100	Trending News Earnings Report Analyst Forecast Gap Down High Trading Volume
BRKR Bruker	3.1255 of 5 stars	$36.39 -1.1%	$49.38 +35.7%	N/A	$5.60B	$3.44B	N/A	11,085	News Coverage Earnings Report Analyst Forecast
RGEN Repligen	3.8138 of 5 stars	$118.21 +0.9%	$170.25 +44.0%	N/A	$6.61B	$738.26M	139.07	2,000	Earnings Report Analyst Forecast
TECH Bio-Techne	3.8079 of 5 stars	$54.74 -0.5%	$72.77 +32.9%	N/A	$8.61B	$1.22B	107.34	3,100	News Coverage Earnings Report Dividend Announcement Analyst Forecast
A Agilent Technologies	4.9621 of 5 stars	$112.15 -2.1%	$163.71 +46.0%	N/A	$32.36B	$6.95B	24.76	18,100	Positive News Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MTD) was last updated on 5/9/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Summary

How does Mettler-Toledo International compare to Repligen?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Mettler-Toledo International (MTD) Competitors

MTD vs. BRKR, RGEN, TECH, A, and BIO

How does Mettler-Toledo International compare to Bruker?

Do institutionals and insiders believe in MTD or BRKR?

Which has higher earnings & valuation, MTD or BRKR?

Does the media refer more to MTD or BRKR?

Is MTD or BRKR more profitable?

Do analysts recommend MTD or BRKR?

Which has more volatility & risk, MTD or BRKR?

Summary

How does Mettler-Toledo International compare to Repligen?

Do institutionals and insiders believe in MTD or RGEN?

Which has higher earnings & valuation, MTD or RGEN?

Does the media refer more to MTD or RGEN?

Is MTD or RGEN more profitable?

Do analysts recommend MTD or RGEN?

Which has more volatility & risk, MTD or RGEN?

Summary

How does Mettler-Toledo International compare to Bio-Techne?

Do analysts recommend TECH or MTD?

Which has better earnings and valuation, TECH or MTD?

Does the media refer more to TECH or MTD?

Do insiders & institutionals have more ownership in TECH or MTD?

Is TECH or MTD more profitable?

Which has more volatility and risk, TECH or MTD?

Summary

How does Mettler-Toledo International compare to Agilent Technologies?

Do analysts recommend A or MTD?

Which has better earnings and valuation, A or MTD?

Does the media refer more to A or MTD?

Do insiders & institutionals have more ownership in A or MTD?

Is A or MTD more profitable?

Which has more volatility and risk, A or MTD?

Summary

How does Mettler-Toledo International compare to Bio-Rad Laboratories?

Which has stronger valuation and earnings, BIO or MTD?

Which has more risk & volatility, BIO or MTD?

Do institutionals & insiders have more ownership in BIO or MTD?

Do analysts rate BIO or MTD?

Does the media prefer BIO or MTD?

Is BIO or MTD more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MTD vs. The Competition

Mettler-Toledo International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools